Authors
Latest:
Building Upon ScaffoldsCancer care is changing rapidly, and understanding and incorporating new practices is challenging both for practicing oncologists and oncology trainees.
Latest:
Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue SarcomasNeoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.
Latest:
Dr. Kumar on Updated Data from the MAIA Trial in Newly Diagnosed Multiple MyelomaShaji Kumar, MD, discusses the updated data from the phase 3 MAIA trial in newly diagnosed multiple myeloma.
Latest:
Clinical Pearls and Future Directions in AL AmyloidosisDr. Zonder and Dr. Kumar share their clinical pearls and perspectives on future directions in the treatment of AL amyloidosis.
Latest:
There's No Place Like a Medical Home: Premier Medical Group Focuses on Full-scale Patient-Centered CareIt's not uncommon for a business to use a superlative in its name, but Premier Medical Group in Poughkeepsie, NY, truly lives up to its moniker.
Latest:
Novel Radiation Oncology Research Makes Population Health Strategies SmarterFor the past 5 years, Montefiore has been a leading Pioneer Accountable Care Organization (ACO) in CMS’ ACO program, which aims to improve the quality of care for Medicare beneficiaries while identifying ways to save healthcare dollars.
Latest:
Dr. Mailankody on BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple MyelomaSham Mailankody, MBBS, discusses research regarding the BCMA CAR T-cell therapy bb2121 in patients with relapsed/refractory multiple myeloma.
Latest:
Dr. Wingo on the Evolution of Surgery in Endometrial CancerShana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses the evolution of surgery in endometrial cancer.
Latest:
Dr. Meehan on Importance of IHC Testing in MelanomaShane A. Meehan, MD, associate professor, Ronald O. Perelman Department of Dermatology, associate professor, Department of Pathology, director of the Dermatopathology Fellowship Training Program, and director of the Dermatopathology Section at New York University Langone Medical Center, discusses the importance of immunohistochemistry (IHC) testing in melanoma.
Latest:
Surgery in Oncology Is Not Always a Simple DecisionThe personalization of cancer care is more elaborately expressed in multidisciplinary tumor conferences and clinical trials.
Latest:
Novel Frontline Regimen Improves PFS in Older Patients With MCLThe 4-drug combination of rituximab, bendamustine, bortezomib, and dexamethasone was found to improve progression-free survival and demonstrated a tolerable safety profile as frontline treatment for patients with mantle cell lymphoma who are ≥65 years.
Latest:
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab ± Olaparib as a First-Line Treatment for Newly Diagnosed Advanced or Recurrent Endometrial Cancer: Results From the Phase III DUO-E/GOG-3041/ENGOT-EN10 TrialShannon Westin, MD, reviews the results of the Phase III DUO-E/GOG-3041/ENGOT-EN10 trial in patients with newly diagnosed advanced or recurrent endometrial cancer.
Latest:
Patient-Centered Approaches to Frontline Low-Grade Ovarian Cancer: Optimizing Treatment, Quality of Life, and Fertility PreservationExpert perspectives from Shannon Westin, MD, MPH, FACOG, on frontline treatment options for patients with newly diagnosed low-grade serous ovarian cancer in the context of recent clinical trial data. Dr. Westin discusses optimizing treatment strategies while prioritizing quality of life and fertility preservation for patients.
Latest:
Dr Westin on Early Findings With Azenosertib in High-Grade Serous Ovarian CancerShannon N. Westin, MD, MPH, FACOG, discusses the DENALI trial of azenosertib in patients with high-grade serous ovarian cancer.
Latest:
Role of Combination I/O in Advanced Endometrial Cancer (EC)Shannon N. Westin, MD, MPH, FACOG, discusses the rationale for the use of combination immunotherapy for advanced and recurrent endometrial cancer.
Latest:
Dr. Puhalla on the Value of Biosimilars in OncologyShannon L. Puhalla, MD, assistant professor of medicine, University of Pittsburgh School of Medicine, medical oncologist and hematologist, UPMC Hillman Cancer Center, discusses the value of biosimilars in oncology.
Latest:
Dr. Ghamande on the AIM2CERV Trial in Cervical CancerSharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.
Latest:
Medical Marijuana Is a Trojan Horse That Pain Physicians Should Refuse to AcceptForty-six percent of Americans want marijuana to be legalized. Seventy percent of Americans support the legalization of medical marijuana.
Latest:
Controversy Surrounds Treatment of High-Risk Smoldering MyelomaA cure concept has not yet been established for asymptomatic and untreated patients with high-risk smoldering myeloma, and debate needs to be initiated surrounding how these patients can be treated sustainably while also taking into account their age, comorbidities, fitness, personal preference, and adverse events of the therapeutic agents.
Latest:
Tabernero Finds New Paths in Gastrointestinal Treatment LandscapeJosep Tabernero, MD, PHD, MSc, is best known for applying translational research against gastrointestinal tumors, with particular focus on colorectal cancer.
Latest:
Today's Nurse Navigator: Educating and Advocating for Cancer PatientsAs both patient advocate and educator, the ONN partners with physicians to help support the cancer patient's journey throughout the course of disease, with the ultimate goal of improving care and outcomes.
Latest:
Compassion Fatigue: When Caring Takes Its TollEvery day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.
Latest:
Changes in Prostate Cancer Presentation for Radiation Oncology CareUSPSTF guidelines may have decreased the number of patients presenting with prostate cancer for radiation oncology care, particularly those with low-risk disease, without a short-term increase in higher-risk disease.
Latest:
Dr. Spencer on Radiation Therapy for Patients With Head and Neck CancerSharon Spencer, MD, professor, chief of Medical Services, Ruby Meredith Outstanding Clinician Endowed Chair, University of Alabama at Birmingham School of Medicine, discusses the types of radiation therapy available to patients with head and neck cancer.
Latest:
Dr. Lewin on the Impact of COVID-19 on Cancer CareSharyn Lewin, MD, FACS, discusses the impact of the coronavirus disease 2019 (COVID-19) on cancer care.
